Compare Panacea Biotech with J.B.Chemicals - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs J.B.CHEMICALS - Comparison Results

PANACEA BIOTECH     Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

J.B.CHEMICALS 
   Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH J.B.CHEMICALS PANACEA BIOTECH/
J.B.CHEMICALS
 
P/E (TTM) x 9.9 16.9 58.8% View Chart
P/BV x 2.1 2.3 90.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 PANACEA BIOTECH   J.B.CHEMICALS
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-19
J.B.CHEMICALS
Mar-18
PANACEA BIOTECH/
J.B.CHEMICALS
5-Yr Chart
Click to enlarge
High Rs354363 97.4%   
Low Rs138255 54.2%   
Sales per share (Unadj.) Rs74.6169.1 44.1%  
Earnings per share (Unadj.) Rs6.716.6 40.2%  
Cash flow per share (Unadj.) Rs15.523.4 66.2%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs57.2172.5 33.2%  
Shares outstanding (eoy) m61.2583.57 73.3%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x3.31.8 180.5%   
Avg P/E ratio x36.818.6 197.7%  
P/CF ratio (eoy) x15.913.2 120.2%  
Price / Book Value ratio x4.31.8 239.9%  
Dividend payout %012.0 0.0%   
Avg Mkt Cap Rs m15,06125,827 58.3%   
No. of employees `0002.33.8 61.3%   
Total wages/salary Rs m1,4712,511 58.6%   
Avg. sales/employee Rs Th1,973.63,747.4 52.7%   
Avg. wages/employee Rs Th635.6665.7 95.5%   
Avg. net profit/employee Rs Th176.8367.8 48.1%   
INCOME DATA
Net Sales Rs m4,56714,135 32.3%  
Other income Rs m45366 12.2%   
Total revenues Rs m4,61214,501 31.8%   
Gross profit Rs m2,0302,178 93.2%  
Depreciation Rs m540570 94.8%   
Interest Rs m1,04835 3,003.7%   
Profit before tax Rs m4861,940 25.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m77552 14.0%   
Profit after tax Rs m4091,387 29.5%  
Gross profit margin %44.415.4 288.4%  
Effective tax rate %15.928.5 55.7%   
Net profit margin %9.09.8 91.3%  
BALANCE SHEET DATA
Current assets Rs m2,41510,470 23.1%   
Current liabilities Rs m9,0772,749 330.2%   
Net working cap to sales %-145.954.6 -267.1%  
Current ratio x0.33.8 7.0%  
Inventory Days Days6555 117.9%  
Debtors Days Days7178 91.3%  
Net fixed assets Rs m8,3335,811 143.4%   
Share capital Rs m61167 36.7%   
"Free" reserves Rs m3,44314,248 24.2%   
Net worth Rs m3,50414,416 24.3%   
Long term debt Rs m4610-   
Total assets Rs m13,75517,649 77.9%  
Interest coverage x1.556.6 2.6%   
Debt to equity ratio x0.10-  
Sales to assets ratio x0.30.8 41.5%   
Return on assets %10.68.1 131.5%  
Return on equity %11.79.6 121.3%  
Return on capital %38.713.7 282.6%  
Exports to sales %20.90-   
Imports to sales %8.10-   
Exports (fob) Rs m954NA-   
Imports (cif) Rs m372NA-   
Fx inflow Rs m1,2036,164 19.5%   
Fx outflow Rs m4671,334 35.0%   
Net fx Rs m7364,829 15.2%   
CASH FLOW
From Operations Rs m1,0491,231 85.2%  
From Investments Rs m-54-208 25.7%  
From Financial Activity Rs m-1,011-595 169.9%  
Net Cashflow Rs m-20427 -4.6%  

Share Holding

Indian Promoters % 74.5 55.4 134.5%  
Foreign collaborators % 0.0 0.3 -  
Indian inst/Mut Fund % 0.6 3.4 17.7%  
FIIs % 1.3 3.9 33.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.6 37.0 63.8%  
Shareholders   10,259 30,437 33.7%  
Pledged promoter(s) holding % 35.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   DISHMAN PHARMA  ELDER PHARMA  VENUS REMEDIES  ALEMBIC PHARMA  WOCKHARDT  

Compare PANACEA BIOTECH With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 70 Points Higher; Telecom and Banking Stocks Advance(Closing)

Indian share markets traded on a positive note throughout the day and ended marginally higher. The BSE Sensex rose over 350 points intraday.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

PANACEA BIOTECH 2017-18 Annual Report Analysis (Annual Result Update)

Mar 27, 2019 | Updated on Mar 27, 2019

Here's an analysis of the annual report of PANACEA BIOTECH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PANACEA BIOTECH. Also includes updates on the valuation of PANACEA BIOTECH.

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PANACEA BIOTECH SHARE PRICE


Nov 15, 2019 (Close)

TRACK PANACEA BIOTECH

  • Track your investment in PANACEA BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PANACEA BIOTECH

PANACEA BIOTECH 8-QTR ANALYSIS

COMPARE PANACEA BIOTECH WITH

MARKET STATS